SEC Form 4 · accession 0001461959-17-000002
Q BioMed Inc. · QBIO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
William S Rosenstadt
Officer — General Counsel · Director
Period of report
Feb 9, 2017
Accepted (ET)
Mar 30, 2017 · 10:31 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001596062
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 9, 2017 | S | 3,800 | $4.40 | D | 88,200 | D | |
| Common Stock | Feb 10, 2017 | S | 5,000 | $4.38 | D | 83,200 | D | |
| Common Stock | Feb 14, 2017 | S | 4,651 | $3.27 | D | 78,549 | D | |
| Common Stock | Feb 16, 2017 | S | 1,000 | $4.00 | D | 77,549 | D | |
| Common Stock | Feb 17, 2017 | S | 1,800 | $3.86 | D | 75,749 | D | |
| Common Stock | Feb 22, 2017 | S | 5,000 | $3.37 | D | 70,749 | D | |
| Common Stock | Mar 7, 2017 | S | 900 | $3.73 | D | 69,849 | D | |
| Common Stock | Mar 9, 2017 | S | 3,800 | $3.56 | D | 66,049 | D | |
| Common Stock | Mar 15, 2017 | S | 1,200 | $3.25 | D | 64,849 | D | |
| Common Stock | Mar 16, 2017 | S | 100 | $2.90 | D | 64,749 | D | |
| Common Stock | Mar 17, 2017 | S | 1,900 | $3.39 | D | 62,849 | D | |
| Common Stock | Mar 21, 2017 | S | 2,200 | $3.40 | D | 60,649 | D | |
| Common Stock | Mar 22, 2017 | S | 5,000 | $3.87 | D | 55,649 | D | |
| Common Stock | Mar 23, 2017 | S | 5,000 | $4.71 | D | 50,649 | D | |
| Common Stock | Mar 24, 2017 | S | 3,700 | $4.56 | D | 46,949 | D | |
| Common Stock | Mar 27, 2017 | S | 5,000 | $4.72 | D | 41,949 | D | |
| Common Stock | Mar 28, 2017 | S | 5,000 | $5.09 | D | 36,949 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the holder on January 17, 2017.